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Diabetic Nephropathy S13Results: Compared with normal control group, the cells exposed to HG
showed up-regulated Notch pathway protein and mRNA expression, up-regu-
lated TGF-b and FN mRNA expressions. Cordyceps sinensis and DAPT
inhibited HG-induced mesangial cell proliferation, down-regulated the
Notch pathway, TGF-b and FN expressions.
Conclusion: We found that high glucose can upregulate the expression of
Notch signaling in GMC while also up-regulate the expression of TGF-b and
FN. Activation of the Notch signaling pathway could induce TGF-b
signaling pathway, which is involved in the pathogenesis of diabetic ne-
phropathy. Our experiments indicate that Cordyceps sinensis may inhibit
high glucose-induced mesangial cell TGF-b and FN overexpression, inhibit
the activation of Notch signaling pathway. However there is no convincing
evidence to prove that Cordyceps sinensis can inhibit the mesangial cell
proliferate through the the Notch signaling pathway. Thus, additional
studies using animal models are wanted to confirm our study in vitro
results.Fig. 1 Effect of incubation with BSA on expression of megalin, TGFbRII,
MCP-1, TGF-bl and p-Smad2/3 in HK-2 cells.http://dx.doi.org/10.1016/j.hkjn.2015.08.039
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Objective: The LncRNA and mRNA expression profiles of normal group, dia-
betes mellitus, diabetic nephropathy patients were investigated by Arrays-
tar human LncRNA/mRNA microarray.
Methods: We obtained serum samples from 21 diabetic nephropathy pa-
tients proven by renal biopsy as nodular diabetic glomerulosclerosis, 9 dia-
betic patients without microalbuminuria (DM) and 19 healthy controls (N).
Serum LncRNA/mRNA expression levels were analyzed with Arraystar Human
LncRNA/mRNA V3.0 expression spectrum biochips. Agilent Feature Extrac-
tion (version 11.0.1.1) software was used to extract the information con-
tained in the microarray images obtained. GeneSpring GX (Agilent
Technologies, version 12.0) software was used to further screen the ob-
tained original expression information of LncRNA and mRNA.
Results: The urinary microalbumin/creatinine ratio and serum creatinine
in diabetic nephropathy patients were higher than that of diabetic pa-
tients and healthy control (p < 0.05). 245 lncRNAs were upregulated and
680 lncRNAs were downregulated in serum of diabetic patients compared
with that of healthy controls. 45 lncRNAs were upregulated and 813
lncRNAs were downregulated in serum of diabetic nephropathy patients
compared with that of diabetic patients. Among them, along with the pro-
gression of diabetes and diabetic nephropathy, lncRNA-ARAP1-AS2 was
gradually increased (2.82 times in DM/N and 2.47 times in DN/DM),
lncRNA-ARAP1-AS1 were gradually reduced (2.24 times in DM/N, 4.79 times
in DN/DM).
Conclusion: The downregulation of lncRNA-ARAP1-AS1 and upregulation of
lncRNA-ARAP1-AS2 upregulated ARAP1 mRNA expression and may involve in
the pathogenesis of DN.Fig. 2 Inhibiting core fucosylation of megalin suppressed endocytosis of
BSA in HK-2 cells.http://dx.doi.org/10.1016/j.hkjn.2015.08.040
0182
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Objective: Albuminuria is a strong risk factor for renal interstitial injury that
impairs proximal tubular epithelial cells (PTECs) through both albumin endo-
cytosis and non-endocytosis mechanisms in diabetic nephropathy. Megalin is
essential for albumin endocytosis mechanism whereas transforming growth
factor-b1 receptor II (TGFbRII) is responsible for albumin non-endocytosis
mechanism. We try to find a common target to inhibit both endocytic and
non-endocytic injury pathway.Methods: Both megalin and TGFbRII are glycoproteins modified by core fuco-
sylation. We investigated the role of core fucosylation in albumin induced-
injury to HK-2 cells. RNAi was performed to suppress expression of megalin,
TGFbRII and FUT8 genes. FACS and confocal microscopy were performed to
observe effect of siRNAs on endocytosis of BSA. Western blot, ELISA and FACS
were performed to determine changes in levels of megalin, TGFbRII, p-
Smad2/3, monocyte chemotactic protein 1 (MCP-1), nuclear factor-kB (NF-
kB), reactive oxygen species (ROS), TGF-b1, Fibronectin, Collagen I and
apoptosis after incubation with bovine serum albumin (BSA) for different
time.
Results: After 4-h incubation with BSA, albumin endocytosis increased, fol-
lowed by upregulation of ROS, MCP-1 and NF-kB. Inhibiting core fucosylation
of megalin suppressed endocytosis of BSA, subsequently, it suppressed
described endocytic injury above. In contrast, after 24-h incubation with
BSA, expression of megalin decreased to 55%, while that of TGFbRII
increased to 1.5-fold of its original level. At the 24-h time point, inflamma-
tion and oxidative stress were weaker than that at the 4-h time point, the
expression of fibronectin and collagen I was significantly upregulated. Inhib-
iting core fucosylation of TGFbRII, suppressed activation of TGFb/TGFbRII/
smad2/3 signaling pathway after incubation for 24 h, followed by downregu-
lation of fibronectin and collagen I.
Conclusion: Inhibiting core fucosylation of megalin and TGFbRII could inhibit
albumin endocytosis and non-endocytosis injury to PTECs simultaneously,
regulating core fucosylation is likely an effective strategy for preventing
against albumin-induced injury to PTECs in diabetic nephropathy.
